39-301: Special Drug Use-Results Survey of DEMSER

JRCT ID: jRCT2031240474

Registered date:08/11/2024

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Pheochromocytoma
• Date of first enrollment: 11/06/2019
• Target sample size: 250
• Study type: Observational

Outcome(s)

Primary Outcome

Safety items : Occurrence of adverse drug reactions and infections, factors considered to influence the safety

Efficacy items : Overall improvement, metanephrines fractionation (24-hour urine collection, spot urine, free), catecholamines 3 fractionation (24-hour urine collection, spot urine, plasma), factors considered to influence the efficacy

Key inclusion & exclusion criteria

• Age minimum: Not applicable
• Age maximum: Not applicable
• Gender: Both
• Include criteria: Patients who have recieved DEMSER for improvement of catecholamine hypersecretion in pheochromocytoma
• Exclude criteria: none

Related Information

• Primary Sponsor: Kuro Toshihiko